Cingulate Inc. (NASDAQ:CINGW) Sees Significant Increase in Short Interest

Cingulate Inc. (NASDAQ:CINGW) saw a significant increase in short interest in the month of May. As of May 29th, there was short interest totaling 10,882 shares, an increase of 186.7% from the May 14th total of 3,796 shares. Based on an average daily volume of 57,882 shares, the short-interest ratio is currently 0.2 days.

Cingulate Price Performance

CINGW stock traded down $0.00 during midday trading on Friday, hitting $0.03. The stock had a trading volume of 200 shares, compared to its average volume of 40,903. The business has a 50-day moving average of $0.02 and a two-hundred day moving average of $0.05. Cingulate has a 52-week low of $0.02 and a 52-week high of $0.18.

About Cingulate

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.